These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9347319)

  • 21. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
    Jerning E; Svantesson GT; Mohell N
    Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
    Hashimoto T; Nishino N; Nakai H; Tanaka C
    Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding thermodynamics of 5-HT1A receptor ligands.
    Dalpiaz A; Borea PA; Gessi S; Gilli G
    Eur J Pharmacol; 1996 Sep; 312(1):107-14. PubMed ID: 8891585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterisation of the 5-HT1A serotonin receptor using the agonist [3H]8-OH-DPAT, and the antagonist [3H]spiperone.
    Sundaram H; Newman-Tancredi A; Strange PG
    Biochem Soc Trans; 1992 May; 20(2):145S. PubMed ID: 1397539
    [No Abstract]   [Full Text] [Related]  

  • 28. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
    Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of serotonin receptors recognized by anti-idiotypic antibodies.
    Tamir H; Liu KP; Hsiung SC; Yu PY; Kirchgessner AL; Gershon MD
    J Neurochem; 1991 Sep; 57(3):930-42. PubMed ID: 1861158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of serotonin1A (5-HT1A) receptor mRNA without binding of [3H]-8-OH-DPAT in peripheral blood mononuclear cells.
    Marazziti D; Palego L; Dal Canto B; Rotondo A; Pasqualetti M; Gino G; Lucacchini A; Ladinsky H; Nardi I; Cassano GB
    Life Sci; 1995; 57(24):2197-203. PubMed ID: 7475972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells.
    Boddeke HW; Fargin A; Raymond JR; Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):257-63. PubMed ID: 1535691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
    Zemlan FP; Schwab EF
    J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
    Iben LG; Mahle CD; Yocca FD
    Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with alpha(2) adrenergic receptors.
    Bonaventure P; Nepomuceno D; Hein L; Sutcliffe JG; Lovenberg T; Hedlund PB
    Neuroscience; 2004; 124(4):901-11. PubMed ID: 15026130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
    Borsini F; Ceci A; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.